Why is Solara Active falling/rising?

As of 24-Jun, Solara Active Pharma Sciences Ltd is experiencing a price increase, currently at Rs 551.55, which reflects a rise of Rs 17.2 or 3.22%. The stock has shown strong performance recently, outperforming its sector by 3.01% today and achieving a consecutive gain over the last three days with a total return of 5.26%. In the past week, the stock has risen by 6.16%, and over the last month, it has increased by 15.23%. Positive financial results over the last three quarters, including a significant growth in profit after tax and a high return on capital employed, contribute to the stock's upward movement. However, the stock's long-term fundamentals are concerning, with a negative CAGR growth in operating profits over the last five years and a high debt to EBITDA ratio, which may weigh on investor sentiment.
Broader market context shows that while Solara has outperformed the benchmark in the short term, with a one-year return of 21.61% compared to the BSE 500's 2.98%, it still faces challenges in the long term. The stock's performance is contrasted by a significant decline in investor participation, as evidenced by a 61.51% drop in delivery volume against the five-day average. Additionally, the high percentage of pledged promoter shares could exert downward pressure in a falling market, indicating potential risks despite the recent positive price movement.